腹部CT上具有特征性的Castleman病表现:76例腹部盆腔淋巴结受累成人病例的多中心回顾性分析
多中心回顾性分析76例病理证实的腹部盆腔Castleman病成人病例,评估优势淋巴结的大小、强化、钙化及结周脂肪改变。58.6%呈富血供强化,56.6%见结周脂肪浸润,富血供者结周脂肪浸润更常见(80.5% vs 20.7%,P < .001);结论认为富血供伴结周脂肪浸润提示Castleman病尤其是透明血管型,但仍需组织活检。
要点
- 腹部盆腔Castleman病优势淋巴结均值长径4.4 cm、短径3.2 cm,22.4%见内部钙化。
- 58.6%病例淋巴结呈富血供强化,强化程度参照主动脉血池衰减主观与客观判定。
- 结周脂肪浸润出现于56.6%病例,富血供组80.5% vs 非富血供组20.7%(P < .001)。
核心结论
- CT上富血供淋巴结伴结周脂肪显著与浸润可提示Castleman病,尤其是透明血管型,但仍需组织取样。
研究设计与样本
- 多中心回顾性研究,5家机构共纳入76例病理证实的腹部盆腔Castleman病成人(平均年龄42.1 ± 14.3岁,38女/38男),回顾评估优势淋巴结及结周脂肪。
关键影像表现/征象
- 优势淋巴结均值长径4.4 ± 1.9 cm、短径3.2 ± 1.7 cm。
- 内部钙化见于22.4%(17/76)。
- 结周脂肪浸润伴或不伴肥大见于56.6%(43/76)。
- 富血供淋巴结中结周脂肪浸润80.5% vs 非富血供20.7%(P < .001)。
- 透明血管型中76.9%为单中心型、71.1%呈富血供、69.2%见结周脂肪浸润。
诊断标准与关键数值
- 富血供强化基于与主动脉血池衰减的主观和客观比较判定。
- 腹部受累单中心型48.7%(37/76)、多中心型51.3%(39/76),其中31例伴腹外受累。
- 病理亚型:透明血管型39例、浆细胞型25例、混合型3例、HHV-8型9例。
临床应用与阅片要点
- 阅片时注意评估优势淋巴结的强化程度及结周脂肪的显著与浸润。
- 富血供淋巴结伴结周脂肪浸润可提示Castleman病,尤其是透明血管型。
- 作者指出该表现提示诊断但仍需组织取样。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Characterize the CT findings of abdominopelvic Castleman disease, including a new observation involving the perinodal fat.
METHODS: Multi-centre search at 5 institutions yielded 76 adults (mean age, 42.1 ± 14.3 years; 38 women/38 men) meeting inclusion criteria of histopathologically proven Castleman disease with nodal involvement at abdominopelvic CT. Retrospective review of the dominant nodal mass was assessed for size, attenuation, and presence of calcification, and for prominence and soft-tissue infiltration of the perinodal fat. Hypervascular nodal enhancement was based on both subjective and objective comparison with aortic blood pool attenuation.
RESULTS: Abdominal involvement was unicentric in 48.7% (37/76) and multicentric in 51.3% (39/76), including 31 cases with extra-abdominal involvement. Histopathologic subtypes included hyaline vascular variant (HVV), plasma cell variant (PCV), mixed HVV/PCV, and HHV-8 variant in 39, 25, 3 and 9 cases, respectively. The dominant nodal mass measured 4.4 ± 1.9 cm and 3.2 ± 1.7 cm in mean long- and short-axis, respectively, and appeared hypervascular in 58.6% (41/70 with IV contrast). Internal calcification was seen in 22.4% (17/76). Infiltration of the perinodal fat, with or without hypertrophy, was present in 56.6% (43/76), more frequent with hypervascular vs non-hypervascular nodal masses (80.5% vs 20.7%; P < .001). Among HVV cases, 76.9% were unicentric, 71.1% appeared hypervascular, and 69.2% demonstrated perinodal fat infiltration.
CONCLUSION: Hypervascular nodal masses demonstrating prominence and infiltration of perinodal fat at CT can suggest the specific diagnosis of Castleman disease, especially the HVV.
ADVANCES IN KNOWLEDGE: Abdominopelvic nodal masses that demonstrate hypervascular enhancement and prominent infiltration of the perinodal fat at CT can suggest the diagnosis of Castleman disease, but nonetheless requires tissue sampling.
引用
- Pickhardt PJ, Wong VK, Mellnick V, et al. Abdominal CT findings characteristic of Castleman disease: multi-centre review of 76 adult cases with abdominopelvic nodal involvement. Br J Radiol. 2024. PMID: 38830085. doi:10.1093/bjr/tqae111
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。